Disclaimer

The trademark information displayed on this page is public information and is provided for informational purposes only. This information may be incomplete, inaccurate, or outdated, and IndiaFilings does not guarantee its accuracy. IndiaFilings is an independent platform and is not associated, affiliated, or connected with any trademark listed in this database. We do not represent or speak on behalf of any such trademark. If you are trying to contact a specific trademark, please use their official channels. IndiaFilings cannot assist with queries directed at other companies.

KYRELVIE

Class 5Status: Accepted & Advertised
Application Number6401989
Trademark Status
Accepted & Advertised
Trademark Class5
Application Date2024-04-24
Proprietor NameAbbVie Inc.
Appropriate OfficeDELHI
StateDELHI
Trademark TypeWORD
User DetailsProposed to be used
Agent NameZEUSIP ADVOCATES LLP[23460]
Agent AddressC-4, Jangpura Extension, New Delhi-110014
Goods And Services Details[CLASS : 5] Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders.

Identical Trademarks

Similar trademarks found for this brand

1 found
BrandClassStatus
KYRELVIE5Accepted & Advertised

Trademark Protection

Automate the monitoring of your trademark application and filing of response to Government Objection or Hearing.

₹9,899+ GST

What's included:

✓
Brand Guard ( 1 application 1 class)
✓
Appointment of Lawyer
✓
Objection
✓
Hearing
✓
Infringement support (1)
✓
Power of Attorney (POA)

Frequently asked questions

Common questions about KYRELVIE.

The current status of trademark application 6401989 for KYRELVIE is Accepted & Advertised.
KYRELVIE is registered under trademark class 5.
The proprietor of KYRELVIE is AbbVie Inc..
Trademark application 6401989 for KYRELVIE was filed on 2024-04-24.